These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25724135)

  • 1. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
    Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD
    Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles].
    Pan Y; Xu H; Zhao HY; Wei G; Zheng JM
    Yao Xue Xue Bao; 2002 May; 37(5):374-7. PubMed ID: 12579845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
    Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
    Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel PLGA-based nanoparticles for the oral delivery of insulin.
    Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
    Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin.
    Patel B; Gupta V; Ahsan F
    J Control Release; 2012 Sep; 162(2):310-20. PubMed ID: 22800582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a non-toxic and non-denaturing formulation process for encapsulation of SDF-1α into PLGA/PEG-PLGA nanoparticles to achieve sustained release.
    Haji Mansor M; Najberg M; Contini A; Alvarez-Lorenzo C; Garcion E; Jérôme C; Boury F
    Eur J Pharm Biopharm; 2018 Apr; 125():38-50. PubMed ID: 29325770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium.
    Gholizadeh S; Kamps JAAM; Hennink WE; Kok RJ
    Int J Pharm; 2018 Sep; 548(2):747-758. PubMed ID: 29042337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
    Jain S; Rathi VV; Jain AK; Das M; Godugu C
    Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
    Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
    J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats.
    Khalil NM; do Nascimento TC; Casa DM; Dalmolin LF; de Mattos AC; Hoss I; Romano MA; Mainardes RM
    Colloids Surf B Biointerfaces; 2013 Jan; 101():353-60. PubMed ID: 23010041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
    Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
    Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Poly(arginine)8 enhanced intestinal absorption of insulin-loaded nanoparticles].
    Liu XL; Zhang WJ; Wei G; Lu WY
    Yao Xue Xue Bao; 2012 Apr; 47(4):512-6. PubMed ID: 22799036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery.
    Wei K; Peng X; Zou F
    Int J Pharm; 2014 Apr; 464(1-2):225-33. PubMed ID: 24463073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid loaded core shell nanoparticles derived from PLGA-PEG-PLGA tri-block copolymers: in vitro and in vivo drug release.
    Gajendiran M; Gopi V; Elangovan V; Murali RV; Balasubramanian S
    Colloids Surf B Biointerfaces; 2013 Apr; 104():107-15. PubMed ID: 23298594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
    Su FY; Lin KJ; Sonaje K; Wey SP; Yen TC; Ho YC; Panda N; Chuang EY; Maiti B; Sung HW
    Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles.
    Peng Q; Zhang ZR; Gong T; Chen GQ; Sun X
    Biomaterials; 2012 Feb; 33(5):1583-8. PubMed ID: 22112760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.